Saorin Gloria, Caligiuri Isabella, Rizzolio Flavio
Department of Molecular Sciences and Nanosystems, Ca' Foscari University of Venice, 30123 Venezia, Italy.
Pathology Unit, Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, 33081 Aviano, Italy.
Semin Cell Dev Biol. 2023 Jul 30;144:41-54. doi: 10.1016/j.semcdb.2022.10.001. Epub 2022 Oct 11.
Microfluidics opened the possibility to model the physiological environment by controlling fluids flows, and therefore nutrients supply. It allows to integrate external stimuli such as electricals or mechanicals and in situ monitoring important parameters such as pH, oxygen and metabolite concentrations. Organoids are self-organized 3D organ-like clusters, which allow to closely model original organ functionalities. Applying microfluidics to organoids allows to generate powerful human models for studying organ development, diseases, and drug testing. In this review, after a brief introduction on microfluidics, organoids and organoids-on-a-chip are described by organs (brain, heart, gastrointestinal tract, liver, pancreas) highlighting the microfluidic approaches since this point of view was overlooked in previously published reviews. Indeed, the review aims to discuss from a different point of view, primary microfluidics, the available literature on organoids-on-a-chip, standing out from the published literature by focusing on each specific organ.
微流控技术开启了通过控制流体流动进而控制营养物质供应来模拟生理环境的可能性。它能够整合电刺激或机械刺激等外部刺激,并能原位监测诸如pH值、氧气和代谢物浓度等重要参数。类器官是自组织形成的三维器官样细胞簇,能够紧密模拟原始器官的功能。将微流控技术应用于类器官,能够生成用于研究器官发育、疾病和药物测试的强大人体模型。在本综述中,在对微流控技术进行简要介绍之后,将按器官(脑、心脏、胃肠道、肝脏、胰腺)对类器官和芯片上类器官进行描述,突出微流控方法,因为这一观点在先前发表的综述中被忽视了。事实上,本综述旨在从一个不同的角度,即微流控技术的角度,来探讨关于芯片上类器官的现有文献,通过关注每个特定器官而在已发表的文献中脱颖而出。